Core Viewpoint - 111, Inc. is set to participate in a fireside chat discussing its Q3 2024 earnings, challenges, opportunities, and NASDAQ share price compliance issue on December 6, 2024 [1][2]. Company Overview - 111, Inc. is a leading tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [5]. - The company provides consumers with improved access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and an offline virtual pharmacy network [5]. - It also offers online healthcare services via its internet hospital, 1 Clinic, which includes online consultations, electronic prescriptions, and patient management services [5]. - 111 operates the largest virtual pharmacy network in China, enabling offline pharmacies to enhance customer service through cloud-based solutions [5]. - The company provides an omni-channel drug commercialization platform, offering services such as digital marketing, patient education, data analytics, and pricing monitoring to its strategic partners [5]. Upcoming Events - The fireside chat will feature Mr. Junling Liu, Co-Founder, Chairman, and CEO of 111, discussing the company's upcoming Q3 2024 earnings report scheduled for November 27, 2024 [2]. - Registration for the event is available through a designated link, and a replay will be accessible on the company's investor relations website [3].

Core Viewpoint - 111, Inc. is set to release its unaudited financial results for Q3 2024 earlier than previously scheduled, now on November 27, 2024, before U.S. market opens [1] Group 1: Financial Results Announcement - The release of unaudited financial results for the third quarter ended September 30, 2024, will occur before the U.S. market opens on November 27, 2024, instead of November 28, 2024 [1] - An earnings conference call will be hosted by the management team at 7:30 AM U.S. Eastern Time on November 27, 2024 [2] Group 2: Conference Call Details - Participants must register online in advance to receive dial-in information, including the passcode and unique access PIN [2] - A live and archived webcast of the conference call will be available on the company's website [3] - A telephone replay of the call will be accessible until December 4, 2024 [3] Group 3: Company Overview - 111, Inc. is a leading tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [4] - The company provides better access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4] - Online healthcare services are offered through its internet hospital, 1 Clinic, which includes online consultations and electronic prescriptions [4] - The company operates the largest virtual pharmacy network in China, enabling offline pharmacies to enhance customer service with cloud-based solutions [4] - 111, Inc. also provides an omni-channel drug commercialization platform, offering services like digital marketing and data analytics to strategic partners [4]

Core Viewpoint - 111, Inc. announced the resignation of Dr. Leon Lian Yong Chen from its board of directors and the appointment of Mr. Yang "Luke" Chen as a new director, effective November 4, 2024, highlighting a transition in leadership that aims to strengthen the company's strategic initiatives in the healthcare sector [1][2][3]. Group 1: Leadership Changes - Dr. Leon Lian Yong Chen has served on the board since May 2019 and has made significant contributions to the company's goals and strategies [2]. - Mr. Yang "Luke" Chen, currently the Senior Finance Executive, has been appointed as a new director, bringing extensive financial expertise and a deep understanding of the business [3]. Group 2: Company Overview - 111, Inc. is a tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [4]. - The company provides better access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4]. - 111, Inc. also offers online healthcare services via its internet hospital, 1 Clinic, which includes online consultations and electronic prescriptions [4].

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, October 30, 2024 at 12:00 p.m. ET.Dr. Gang Yu, Co-Founder and Executive Chairman of 111, will dis ...

SHANGHAI, Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024.111's management team will host an earnings conference call at 7:30 AM U ...

SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that new fulfillment centers in South and Central China began operations in Guangzhou, Guangdong Province, and Wuhan, Hubei Province, respectively. These strategic expansions mark a significant step forward in enhancing its national ...

SHANGHAI, Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today was informed by co-founders of the Company, Dr. Gang Yu and Mr. Junling Liu, that they have started purchasing shares from time to time from their personal funds during the trading window and intend continue to purchase additional shares. Th ...

111, Inc. (NASDAQ:YI) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Call Participants Xipeng Feng - CICC Zoe Bian - Citi Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. Junling Liu, Co-Founder, Chairman a ...

Exhibit 99.1 111, Inc. Announces First Quarter 2024 Unaudited Financial Results • Turned to Quarterly Operational Profitability for the First Time • Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% • Achieved Positive Operating Cash Flow SHANGHAI, May 23, 2024 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream ...

Maintained Operational Profitability for the Second Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoYHeld Positive Operating Cash Flow for Two Consecutive QuartersSHANGHAI, Aug. 29, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financia ...